
Nanomics Biotech offers a platform for data-driven biomarker discovery in precision medicine. Proteonano combines nanotechnology, automation, and AI to measure thousands of disease biomarkers with high throughput. It provides an automated, user-friendly workflow for multiplexed biomarker discovery and validation. Target customers include researchers and pharma teams pursuing early diagnosis, patient stratification, trial matching, and drug monitoring. The approach aims to scale proteomics research and accelerate clinical translation.

Nanomics Biotech offers a platform for data-driven biomarker discovery in precision medicine. Proteonano combines nanotechnology, automation, and AI to measure thousands of disease biomarkers with high throughput. It provides an automated, user-friendly workflow for multiplexed biomarker discovery and validation. Target customers include researchers and pharma teams pursuing early diagnosis, patient stratification, trial matching, and drug monitoring. The approach aims to scale proteomics research and accelerate clinical translation.